Locations

Berkeley, CA, USA · South San Francisco, CA, USA

industry

Biotechnology · DeepTech · Health

Size

11-50 employees

Stage

Pre Seed

founded in

2016

GenEdit, Inc. focuses on the development of novel, non-viral, nanoparticle-based delivery technology and enabling next generation CRISPR-based gene therapies. The foundation of our CRISPR-Nanoparticle Technology Platform is based on successfully engineering the individual components of the CRISPR system to overcome the limitations of existing delivery vehicles for CRISPR-based therapeutics.

Something looks off?
Open jobs at GenEdit

On-site & Remote